The future of drug development
Resverlogix is committed to developing epigenetic therapies for the benefit of patients with chronic disease. Their current clinical program focuses on advancing their lead compound (apabetalone) and…
Read More...
Browsing Tag
Biotechnology Company
Resverlogix: The Future of Drug Development
Developing safe, epigenetic therapeutics for people suffering from chronic illnesses
Resverlogix is a late-stage clinical…
